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1.0  Introduction 
Throughout medical history there have been efforts to develop an ideal 
method of performing intestinal anastomoses. Over a century ago 
Nicholas Senn of Chicago, in his presidential address to the 
Association of Military Surgeons in 1893, said ‘We have reasons to 
believe that the technique of intestinal suturing remains an unfinished 
chapter and the ideal method of uniting intestinal wounds has yet to be 
devised’1. That statement holds true even today, more than a century 
later. Wound healing that occurs at colonic anastomoses is 
multifactorial and disturbed healing results in leakage or rupture with 
associated morbidity. Low colonic anastomoses have clinically 
significant leakage rates of around 16%2 with radiologically 
demonstrable ones ranging from 27 – 49%3,4. Clinical anastomotic 
leaks necessitate a diversion stoma often prophylactically5. The healing 
of colonic anastomoses is a subject of much debate and research but 
the factors involved are as yet imperfectly understood3. This study 
proposes to look at the role of one such intraluminal factor in the 
healing of colonic anastomoses with possible clinical ramifications.  
The healing of colonic anastomoses is a subject of great interest to 
surgeons due to the high rates of morbidity associated with them even 
today. There have been many attempts to reduce the rate of                                
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 complications with different authors suggesting various modifications 
in the technical construction of these anastomoses, the use of 
protective stomas, preoperative preparation, early identification of leaks 
and post-operative management. However, the factors contributing to 
the healing of these anastomoses are many and there is still much 
research required to standardise the process and minimise morbidity. 
An area which has not yet been fully understood is the physiological 
basis of colonic healing and the factors that promote and inhibit it. 
While the physiology of colonic healing has been described, there has 
not yet been much work attempting to identify treatment options that 
would encourage early colonic healing at a molecular level. This study 
was carried out in an attempt to detect a modifiable factor involved in 
wound healing that could be manipulated to hasten colonic healing 
following anastomosis. 
The premise of the study was that butyrate strengthens colonic 
anastomoses. This was assumed considering previous work done 
using butyrate. It has been proved that stimulation of the lumen by 
even non-nutrient substances provided strong trophic stimuli to the 
colon.6 Even infusion of an electrolyte solution enhanced colonic 
healing in comparison to complete diversion proving that mechanical, 
non-nutrient stimulation of the enterocytes promotes healing. The 
physiological production of butyrate in the colon and its role in 
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providing upto 80% of colonocyte energy made it a natural choice as a 
factor that would assist colonic healing.  
Considering the weight of evidence suggesting that butyrate played a 
role in cytoprotection and wound healing, this study was carried out to 
investigate that role and look at the factors that may cause this effect.  
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2.0  Aims and Objectives 
1. To assess the effect of intraluminal butyrate on the healing of 
anastomoses in rat colon by testing mechanical strength. 
2. To compare the differences in the mechanical strength of 
ascending and descending colon with and without treatment with 
butyrate. 
3. To assess the expression of Matrix Metalloproteinases in the 
healing colon and study the effect of butyrate on this expression. 
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3.0 Review of Literature 
3.1 Background 
The body’s ability to replace injured or dead cells and repair tissues 
following inflammation is critical to survival. The repair of tissues 
involves two distinct processes – replacement of injured or dead cells 
by cells of the same type or regeneration and replacement by 
connective tissue called fibroplasia or fibrosis. Both these processes 
are determined by essentially similar mechanisms involving cell 
migration, proliferation and differentiation as well as cell-matrix 
interactions. The orderly regeneration of epithelial tissue requires a 
specialised extracellular matrix called the basement membrane which 
acts as a scaffolding. These processes are the basis of the complex 
phenomenon of wound healing. 
 
3.2  Regeneration 
Cell proliferation is stimulated by cell injury, death or mechanical 
deformation of tissues. The cell growth cycle consists of the G1 
(presynthetic), S (DNA synthesis), G2 (premitotic and M (mitotic) 
phases. Most tissues of the body contain a combination of continuously 
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dividing cells or labile cells, quiescent or stable cells that occasionally 
enter into the cell cycle and nondividing cells. Cell replication is 
controlled mainly by the factors in the microenvironment which 
stimulate or inhibit cell proliferation. The most important factors are 
those that recruit resting or quiescent cells into the cell cycle.7 
The columnar epithelium of the gastrointestinal tract contains a greater 
proportion of labile cells that follow the cell cycle from one mitosis to 
the next and continue to proliferate throughout life.  The connective 
tissue and mesenchymal cells are quiescent in adult mammals, but 
proliferate in response to injury. Fibroblasts in particular proliferate 
widely and constitute the connective tissue response to inflammation. 
3.2.1 Control of Normal Cell Growth 
Molecular events in cell growth are complex involving an array of 
intercellular pathways. Aberrations in such pathways may underlie the 
uncontrolled growth in cancer as well as abnormal cellular responses 
to disease processes. There are three schemes of intercellular 
signaling – autocrine (cells responding to substances they secrete 
themselves, paracrine (cells responding to substances produced in 
close proximity) and endocrine (cells responding to hormones secreted 
at a distant site).8  
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Certain growth factors induce cell proliferation by affecting the 
expression of genes controlling normal growth and are called 
protooncogenes. Aberrations in the structure of these protooncogenes 
convert them into oncogenes which lead to the uncontrolled cell growth 
that occurs in cancer. The processes of normal and abnormal cell 
division thus follow the same pathways.9 
3.2.2 Cell Surface Receptors 
Cell growth is initiated by the binding of a signaling agent or ligand, 
usually a growth factor, to a specific receptor protein. The receptor 
ligand complex initiates a specific cellular response. There are three 
major classes of cell surface receptors. 
i. Receptors with intrinsic kinase activity have an extracellular 
domain for ligand binding, a single tramsmembrane region and a 
cytosolic domain which can have either tyrosine kinase activity or less 
commonly serine/threonine. Dimeric growth factors bind two receptors 
and form stable dimmers. Dimerisation is followed by 
autophosphorylation where one receptor molecule phosphorylates the 
other forming binding sites for a series of cytosolic proteins.10 Binding 
of cytosolic proteins to the phosphorylated tyrosine residues on the 
activated receptor generate a signal transduction cascade which 
commit the cell to enter the S phase of the cell cycle. 
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ii. Receptors without intrinsic catalytic activity have a cytosolic 
domain which directly associates with and activates protein tyrosine 
kinases in the cytosol which in turn phosphorylates the receptor. 
Receptors for many cytokines fall in this category and this is termed the 
cytokine receptor superfamily.11 
iii. G protein linked receptors contain seven transmembrane loops 
and are called seven spanning receptors. Ligand binding activates a 
cytosolic G protein complex that then activates an effector system 
generating intracellular second messengers.12 
3.2.3 Signal Transduction Systems 
Extracellular signals that are detected by the cell surface receptors are 
then converted into intracellular signals which generate specific cellular 
responses. This process is called signal transduction. Signal 
transduction systems are arranged as networks of sequential protein 
kinases. The important systems are the mitogen-activated protein 
(MAP) kinase, phosphoinositide-3 (PI-3) kinase, inositol lipid (IP3), 
cyclic adenosine monophosphate (cAMP), the Janus kinases/signal 
transducers and activators of transcription (JAK/STAT) signaling 
system and the stress kinase system. 
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3.2.4 Transcription Factors 
The signal information received by the cell surface receptors is 
transferred by the signal transducers to the nucleus where regulation of 
gene expression occurs. This is controlled by transcription factors 
which include protooncogenes and tumor suppressor genes 
(antioncogenes). They have a modular structure with domains for DNA 
binding and transcriptional regulation (regulatory domain). The DNA 
binding domain binds to DNA by distinct molecular mechanisms 
(homeodomain, zinc finger).13 The regulatory domain either increases 
(activation domain) or decreases (repression domain) transcription. 
3.2.5 Cell Cycle Regulation 
The passage of cell through specific phases of the cell cycle is 
regulated by two types of molecular controls – a cascade of protein 
phosphorylation pathways involving cyclins and a set of checkpoints 
that monitor completion of events and sometimes delay progression to 
the next phase of the cycle. 
Cyclins are a group of proteins that control the entry and progression 
of cells through the cell cycle. The cyclins (A, B and E) form complexes 
with specific proteins called cyclin dependent kinases (CDKs).14 These 
complexes regulate the passage of the cells to the next stage of the 
cycle. The levels of the kinases peak during specific phases of the 
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cycle and are then degraded rapidly as the cell enters the next phase 
of the cell cycle15 by the ubiquitin-proteasome pathway.16 The activity 
of the CDK complexes is also determined by binding of CDK inhibitors 
such as p21 and p27, as well as other kinases and phosphates.17 
Checkpoints provide a surveillance mechanism by sensing problems 
in DNA replication, repair and chromosome segregation.18 When 
checkpoints are activated, they send signals to the cell cycle machinery 
that arrest the cell cycle. An example is the p53 tumour suppressor 
gene that is activated in response to DNA damage and inhibits the cell 
cycle by increasing the expression of the CDK inhibitor, p21. 
3.2.6 Growth Factors 
Growth factors are specific polypeptides that influence the mitotic 
cycle. They may act on a variety of cell types or have specific target 
locations. They also have effects on cell locomotion, contractility and 
differentiation that influence wound healing. Table 3.1 lists some of the 
important growth factors. 
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3.3 Extracellular Matrix 
Cell multiplication and differentiation occurs in intimate contact with the 
extracellular matrix (ECM). There is now evidence that the ECM 
critically influences these cell functions.19 The ECM is secreted locally 
and forms a network of macromolecules in the spaces surrounding the 
cells. Three groups of macromolecules associate to form the ECM. 
i. Fibrous structural proteins like collagens and elastins 
ii. Adhesive glycoproteins like fibronectin and laminin 
iii. A gel of proteoglycans and hyaluronan. 
The ECM has many functions.20 It sequesters water molecules to 
provide turgor to soft tissues and minerals to provide rigidity to skeletal 
tissues. It provides a reservoir for growth factors controlling cell 
proliferation. It also provides a base for cells to migrate, adhere and 
proliferate directly influencing the form and function of cells. The 
degradation of the ECM accompanies wound healing as well as tumour 
invasion. 
3.3.1 Collagen  
Collagens provide the extracellular framework for all multicellular 
organisms. They have a triple helix of three polypeptide α chains and 
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about 30 different chains form 14 different collagen types.21 Types I, II 
and III are fibrillar and are abundant in the interstitium. Types IV, V and 
VI are nonfibrillar or amorphous and are present in the basement 
membrane and interstitium. The α chains are synthesised on the 
ribosome and then subjected to enzymatic modifications including 
hydroxylation of proline and lysine residues. Following modification, the 
procollagen chains align to form the triple helix. The collagens are then 
secreted from the cell, during which time procollagen peptidases clip 
the terminal propeptide chains forming fibrils. Specific lysine and 
hydroxylysine residues are oxidized by lysine oxidase resulting in 
cross-linkages between α chains of adjacent molecules stabilizing the 
collagen array and contributing to the tensile strength. 
3.3.2 Elastic fibres  
While tensile strength of the tissues is provided by collagen, the ability 
to recoil is provided by elastic fibres.22 These consist of a central core 
made largely of elastin, a 70-kD protein. Similar to collagen, it is rich in 
glycine, proline and alanine while it contains little hydroxyproline and 
no hydroxylysine in contrast to collagen. The central elastin core is 
surrounded by a microfibrillar network mainly consisting of fibrillin, a 
350-kD glycoprotein. Fibrillin associates either with itself or with other 
components of the ECM.23 This network is the scaffolding on which 
elastin is laid down. 
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3.3.3 Adhesive Proteins. 
The ECM component are linked to one another and to the cells by 
adhesive glycoproteins and integrins. The major adhesive 
glycoproteins are fibronectin and laminin. Fibronectin is directly 
involved in attachment, spreading and migration of cells24 while laminin 
is the major glycoprotein in the basement membrane.25 
3.3.4 Integrins  
Integrins are the most important cell surface receptors that mediate 
cellular attachment to the ECM. They are transmembrane 
glycoproteins consisting of a single β chain with a series of α chains.26 
The extracellular domains of integrins bind laminin, fibronectin and 
many other components of the ECM by recognizing specific amino acid 
sequences. This causes a clustering of receptors with formation of 
focal adhesions which are links of the integrins to intracellular 
cytoskeleton complexes.27 These integrin-cytoskeleton complexes 
function as activated receptors and activate components of the 
intracellular signaling systems. In this way, integrins help in organising 
the actin cytoskeleton as well as transduction of signals from the ECM 
to the cell. Integrins also play important roles in cell-cell interactions 
and are involeved in leukocyte adhesion and extravasation, platelet 
aggregation, developmental processes and wound healing.  
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The integrin-cytoskeleton linkage may also be the key to unraveling the 
tensegrity hypothesis.28 Physical forces of gravity, hemodynamic 
stresses, and movement play a critical role in tissue development. Yet, 
little is known about how cells convert these mechanical signals into a 
chemical response. It has been suggested that the mechanical linkage 
between integrins and the cytoskeleton system may be the mechanism 
for the conversion of mechanical forces into biochemical signals29 and 
this theory is under investigation. 
3.3.5 Other ECM components  
The other main components of the ECM are matricellular proteins, 
hyaluronan and proteoglycans. Matricellular proteins are secreted 
proteins that interact with matrix proteins, cell surface receptors or 
other molecules that in turn interact with the cell surface. Hyaluronan 
serves as a ligand for core proteins of the ECM as well as a backbone 
for large proteoglycan complexes.30 Due to its capability to bind water, 
it forms a viscous gel that provides turgor to connective tissue as well 
as serves as a lubricant in the connective tissues like cartilage. It also 
associates with cell surface receptors that regulate cell proliferation 
and migration. Proteoglycans are a group of core proteins attached to 
polysaccharides called glycosaminoglycans.31 Heparan sulphate, 
chondroitin sulphate and dermatan sulphate belong to this group and 
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have diverse roles in regulating connective tissue permeability and 
structure as well as cell growth and differentiation. 
 
3.4 Extracellular Processes of Tissue Repair 
The destruction of tissues causes damage to the cellular network as 
well as the stromal framework of the tissue. Even in tissues where the 
cells are capable of regeneration, some repair occurs by the 
replacement of nonregenerated cells by connective tissue. This 
noncellular tissue repair has three components. 
i. Angiogenesis 
ii. Fibrosis 
iii. Remodeling 
3.4.1 Angiogenesis  
The formation of blood vessels is accomplished by two processes. 
Vasculogenesis involves the organisation of lakes of angioblasts into a 
primitive vascular network. Neovascularisation involves the formation 
of new vessels from capillary buds sent out from pre-existing blood 
vessels.32 This involves a series of steps beginning with the proteolytic 
degradation of the parent vessel basement membrane and formation of 
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a capillary sprout. Endothelial cells then migrate towards this bud, 
proliferate and mature with the inhibition of further growth and the 
formation of capillary tubes. Peri-endothelial cells like smooth muscle 
cells are then recruited to provide support to the endothelial tubes.  
These steps are controlled by interactions between growth factors, 
vascular cells and the ECM. The most important growth factor in adult 
tissues undergoing physiological angiogenesis is the family of Vascular 
Endothelial Growth Factors (VEGF). An embryological model33 has 
been developed that elucidates the important role of VEGF in 
promoting angiogenesis, increasing vascular permeability, stimulating 
endothelial cell migration and proliferation and regulating the 
expression of other growth factors.  
The integrins and matricellular proteins also are involved in the control 
of the motility and migration of the endothelial cells. Certain proteases 
like plasminogen activators and matrix metalloproteinases play an 
important role in the remodeling that occurs during endothelial invasion 
as well as in cleaving extracellular proteins to form fragments like 
endostatin that regulate angiogenesis. 
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Table 1. Growth factors – Their Source and Primary Activity 
Factor     Principal Source     Primary Activity         Comments 
PDGF platelets, endothelial cells, placenta 
promotes proliferation 
of connective tissue, 
glial and smooth 
muscle cells 
two different 
protein chains form 
3 distinct dimer 
forms; AA, AB and 
BB 
EGF submaxillary gland, Brunners gland 
promotes proliferation 
of mesenchymal, glial 
and epithelial cells 
 
TGF-α common in transformed cells 
may be important for 
normal wound healing related to EGF 
FGF 
wide range of cells; 
protein is associated 
with the ECM 
promotes proliferation 
of many cells; inhibits 
some stem cells; 
induces mesoderm to 
form in early embryos 
at least 19 family 
members, 4 distinct 
receptors 
NGF  
promotes neurite 
outgrowth and neural 
cell survival 
several related 
proteins first 
identified as proto-
oncogenes; trkA 
(trackA), trkB, trkC 
Erythropoietin Kidney 
promotes proliferation 
and differentiation of 
erythrocytes 
  
TGF-β 
activated TH1 cells (T-
helper) and natural 
killer (NK) cells 
anti-inflammatory 
(suppresses cytokine 
production and class II 
MHC expression), 
promotes wound 
healing, inhibits 
macrophage and 
lymphocyte 
proliferation 
at least 100 different 
family members 
IGF-I primarily liver promotes proliferation of many cell types 
related to IGF-II and 
proinsulin, also 
called Somatomedin 
C 
IGF-II variety of cells 
promotes proliferation 
of many cell types 
primarily of fetal origin 
related to IGF-I and 
proinsulin 
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3.4.2 Fibrosis  
Within 24 hours following tissue injury, fibroblasts and vascular 
endothelial cells begin proliferating to form a specialised tissue called 
granulation tissue that is the hallmark of healing. It is within this tissue 
that fibrosis begins. There are two processes involved in fibrosis. The 
initial step is the migration of fibroblasts to the site of the injury followed 
by their proliferation. The second step is the deposition of ECM by the 
fibroblasts.  
The migration and proliferation of fibroblasts are triggered by a number 
of growth factors given in Table 1. These growth factors are derived 
from platelets, activated endothelium and a variety of inflammatory 
cells like macrophages, mast cells, eosinophils and lymphocytes. The 
most important growth factor in fibrosis is TGF-β. TGF-β is produced by 
most cells present in granulation tissue and has many different actions. 
It causes fibroblast migration and proliferation, increased synthesis of 
collagen and fibronectin, decreased degradation of ECM by 
metalloproteinases, migration of monocytes and stimulating 
angiogenesis. 
The migration and proliferation of fibroblasts gradually decreases and 
they begin to synthesise and deposit ECM components, especially 
fibrillar collagens, on the granulation tissue. This process continues for 
 20 
many weeks depending on the size of the wound. The growth factors 
regulating fibroblast proliferation now influence collagen formation. The 
net accumulation of collagen depends on collagen synthesis as well as 
degradation, both of which occur simultaneously. Vascular regression 
takes place and the granulation tissue is gradually converted into an 
avascular scar. 
3.4.3 Remodeling 
The transformation of granulation tissue to scar tissue involves a 
number of changes in the ECM that are mainly brought about by the 
synthesis and degradation of collagen. These two processes that occur 
simultaneously bring about remodeling of the connective tissue and 
stable scar formation. The degradation of collagen is brought about by 
a group of endopeptidases called matrix metalloproteinases (MMPs). 
Activated MMPs are inhibited by a family of tissue inhibitors of 
metalloproteinase (TIMP) which are produced by most mesenchymal 
cells. The equilibrium between MMPs and TIMPs is a key factor in 
tissue remodelling.  
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3.5 Matrix Metalloproteinases (Matrixins) 
Matrix metalloproteinases (MMPs), otherwise called matrixins, are a 
group of endopeptidases that play a vital role in the healing process. 
They are collagenases and act by breaking down collagen. This 
function of breakdown of extracellular matrix (ECM) is essential for 
embryonic development, morphogenesis, reproduction, and tissue 
resorption and remodeling34. Coordinate synthesis and degradation of 
ECM components is also necessary for many important 
pathophysiological processes involved in inflammation, such as 
leucocyte invasion,35 epithelial migration,36,37 neovascularisation,38 and 
wound healing.39 Disturbance of the balance between synthesis and 
degradation of ECM components may result either in progressive organ 
destruction, as seen for example in ulcer formation,40 or excessive 
deposition of collagens resulting in fibrosis.41 The expression of most 
matrixins is transcriptionally regulated by growth factors, hormones, 
cytokines, and cellular transformation42. The proteolytic activities of 
MMPs are precisely controlled during activation from their precursors 
and inhibition by endogenous inhibitors, macroglobulins, and tissue 
inhibitors of metalloproteinases (TIMPs). The first MMP activity 
discovered was a collagenase in the tail of a tadpole undergoing 
metamorphosis. To date, 24 different vertebrate MMPs have been 
identified, of which 23 are found in humans.43  
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Table 2 
Vertebrate members of the matrixin family  
See Appendix 3 for domain composition. 
Protein MMP Domain composition 
Collagenase 1 MMP-1 B 
Gelatinase A MMP-2 C 
Stromelysin 1 MMP-3 B 
Matrilysin MMP-7 A 
Collagenase 2 MMP-8 B 
Gelatinase B MMP-9 D 
Stromelysin 2 MMP-10 B 
Stromelysin 3 MMP-11 E 
Macrophage elastase MMP-12 B 
Collagenase 3 MMP-13 B 
MT1-MMP MMP-14 F 
MT2-MMP MMP-15 F 
MT3-MMP MMP-16 F 
MT4-MMP MMP-17 F 
Collagenase 4 (Xenopus) MMP-18 B 
(No trivial name) MMP-19 B 
Enamelysin MMP-20 B 
XMMP (Xenopus) MMP-21 G 
CMMP (chicken) MMP-22 B 
(No trivial name) MMP-23 H 
Courtesy. Nagase H, Woessner JF Jr. Matrix Metalloproteinases. J Biol Chem. 1999; Jul 
30; 274(31):21491-4. 
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The sequence homology with collagenase 1 (MMP-1), the cysteine 
switch motif in the propeptide that maintains MMPs in their zymogen 
form (proMMP), and a zinc-binding motif in the catalytic domain are the 
signatures used to assign proteinases to this family. MMPs generally 
consist of a prodomain, a catalytic domain, a hinge region, and a 
hemopexin domain (see Appendix 3). On the basis of substrate 
specificity, sequence similarity, and domain organization, vertebrate 
MMPs can be divided into six groups – collagenases, gelatinases, 
stromelysisn, matrilysins, membrane bound MMPs and other MMPs 
(see Table 2). The complex three dimensional structure of a few MMPs 
have been described using X-ray crystallography and nuclear magnetic 
resonance (NMR) and is shown in Appendix 2. 
The activaton of proMMPs to MMPs takes place in a stepwise fashion 
either by proteinases in vivo or by a number of chemical agents in vitro. 
Most activation occurs extracellularly, but recently, there have been 
reports of intracellular activation as well as cell surface activation. 
Following activation, the MMPs fulfil a number of roles in cellular 
physiology. A major function of MMPs is thought to be the removal of 
ECM in tissue resorption. However, the ECM is not simply an 
extracellular scaffold; it also acts as a reservoir of biologically active 
molecules, such as growth factors.44 Some ECM components can 
express cryptic biological functions on proteolysis. Hence, degradation 
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of ECM components by MMPs can alter cellular behavior and 
phenotypes (Table 2). Add to this the ever expanding number of non-
ECM proteins that are MMP substrates and exert biological activities45, 
and the complexity of the role of MMPs in health and disease is 
evident.  
Recently, MMPs have been implicated as one of the main factors 
contributing to mucosal ulceration in inflammatory bowel disease 
(IBD).46,47,48,49,50,51 Although these diseases are undoubtedly caused by 
excessive immune reactivity in the mucosa, the end stage effector 
molecules for mucosal degradation appear to be the MMPs secreted by 
cytokine activated stromal cells.52 There have also been reports on the 
role of MMPs in colonic anastomotic healing.  Excessive matrix 
metalloproteinase activities have been implicated in the pathogenesis 
of intestinal anastomotic dehiscence53 and synthetic metalloproteinase 
inhibitors like marimastat are being studied in a therapeutic role54 
 
3.6 Tissue Inhibitors of Metalloprotinases (TIMPs)  
TIMPs (21-30 kDa) are the major endogenous regulators of MMP 
activities in the tissue, and four homologous TIMPs (TIMPs 1 to 4) have 
been identified to date.55 The crystal structure of the complex formed 
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between TIMP-1 and the catalytic domain of MMP-3 was first 
determined by Gomis-Rüth et al.56 
TIMPs form classic noncovalent bimolecular complexes with the active 
forms of MMPs and under certain circumstances with their latent forms 
as well. TIMPs inhibit the activity of the fully competent MMP and also 
appear to block or retard MMP precursor activation.57,58 The role 
played by TIMPs in regulating matrix degradation may therefore be 
exerted not only by classic proteinase elimination but also by a perhaps 
even more potent effect, namely, the interceptive blockage of MMP 
activation. TIMPs appear to be distributed widely in tissues and 
fluids59,60 and to be expressed by many different normal and 
transformed cell types. 
TIMPs have been found to play a role in many cell physioplogical 
functions especially tumorigenesis, carcinogenesis, metastasis and 
angiogenesis. TIMPs have been found to have mitogenic effects on 
many cells (especially tumour cells) by inhibiting apoptosis though they 
inhibit tumour cell growth when overexpressed. These effects are in 
addition to the biological functions influenced by their role in inhibiting 
MMPs and are in fact independent of MMPs.61,62 TIMPs have also 
been found to be involved in the pathogenesis of ulcerative colitis along 
with MMPs with Louis et al finding increased expression of TIMP-1 at 
ulcerated sites of mucosa, but no increased expression in either 
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controls or patients with UC.63 The significant correlation of TIMP-1 
levels with clinical and endoscopical signs of UC activity have led to the 
suggestion that it may be used as a biomarker of the disease.64 
3.6 Processes of Wound Healing with Specific Reference 
to Colonic Healing 
Wound healing is a series of events that take place following tissue 
injury in an orderly manner. This process has the same basic steps in 
all human tissue, though the healing in different organs may differ in 
certain processes as individual organs contain specialised cells that 
provide organ specificity to the healing process. The basic steps 
involved in wound healing are 
i. Initiation of inflammation by injury 
ii. Parenchymal cell regeneration 
iii. Migration and proliferation of parenchymal and connective tissue 
cell to the site of injury 
iv. Synthesis of proteins and laying down of ECM 
v. Remodelling 
vi. Organisation of collagen providing wound strength. 
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3.6.1 Anatomical and Physiological Considerations 
The wall of the intestine histologically consists of four layers – mucosa, 
submucosa, muscularis propria and serosa. These are seen in the 
whole gut tube from the esophagus to the rectum reflecting the general 
structural organisation of the entire GI tract.  
The innermost layer of the colon wall is the mucosa, which is 
essentially the same in the whole colon. This layer consists of a layer 
of nonkeratinising stratified squamous epithelium overlying the lamina 
propria mucosa. The laminal propria contains blood vessels, 
lymphatics and nerve endings as well as a number of mesenchymal 
cells and inflammatory cells such as macrophages, lymphocytes and 
mast cells. Surrounding the lamina propria is the muscularis mucosae, 
a thin, vertical muscle layer. In contrast to the small intestine, the 
colonic mucosa has no villi and is flat. The mucosa is punctuated with 
numerous straight tubular crypts that extend down to the muscularis 
mucosa. The surface epithelium is composed of columnar absorptive 
cells which have shorter, less abundant microvilli than the small 
intestine and goblet cells. The crypts contain abundant goblet cells, 
endocrine cells and indifferentiated crypt cells. Paneth cells are 
occasionally present in the base of the crypts in the caecum and 
ascending colon. 
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The mucosal lining of the gastrointestinal tract is composed of a rapidly 
proliferating and continually renewing sheet of epithelial cells that serve 
a variety of specialized physiologic functions including selective 
absorption of nutrients, surface hydration, immune surveillance, and 
the formation of a permeability barrier between the hostile luminal 
environment and the body interior. In the intestine, the epithelial cells 
that carry out these tasks are anatomically compartmentalized and 
derive from a population of rapidly proliferating stem cells located 
several cell positions above the base of the crypts. Over the course of 
a 4- to 6-day lifespan, undifferentiated crypt cells migrate out of the 
proliferative crypt zone along the so-called crypt-villus axis, where they 
acquire phenotypic characteristics of mature absorptive enterocytes 
before undergoing apoptotic cell death.65 
The submucosa is the most important layer in the GI tract with regard 
to anastomotic healing, since it is the support for the sutures.66 It is 
composed of loose connective tissue containing the majority of matrix 
proteins. The composition of the matrix, however, is different from that 
of skin. It contains large amounts of collagen type I, less of type III 
collagen, and also type V collagen. Smooth muscle cells are the 
predominant matrix producers. The submucosa is richly vascularized, 
containing an arterial and venous plexus as well as a network of 
lymphatics. 
 29 
The muscularis propria consist of two thick layers of smooth muscle 
cells, an inner circular layer and outer longitudinal layer. The serosa or 
the visceral peritoneum contains mesothelial cells on a thin layer of 
mesenchymal cells and matrix. It is rich in vasculature and lymphatics. 
The same four layers exist throughout the whole GI tract. The 
esophagus and rectum lack serosal coverage: They are the site of 
increased risk of anastomotic failure as well as increased stricture 
formation. 
The colon reabsorbs water, electrolytes (sodium, chloride), and short 
chain fatty acids (butyrate). It further secretes mucus to soften the 
feces. In contrast to the small bowel, the colon contains large amounts 
of aerobic and anaerobic bacteria. One gram of feces contains 
approximately 1011 bacteria, which represents 3% of the stool mass.67  
 
3.6.2 Phases of Healing. 
The three phases of GI healing are inflammation, proliferation, and 
tissue remodeling. As with reepithelialization of the skin, if the mucosa 
is the only injured layer, it can be reformed by migration and 
proliferation. Full-thickness injury provokes a fibroblastic response 
resulting in scar formation. 
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The inflammatory phase begins immediately after the injury and is 
characterized by cell infiltration and edema formation. Edema is mainly 
confined to the submucosa.68  It subsides completely only by the end of 
the second week. Granulocytes are the predominant cell type in the 
first 24 hrs, and macrophages follow 48 hrs after clean surgical injury. 
Fibroblasts and smooth muscle cells are recruited and produce matrix 
proteins for laying down of ECM in the submucosa, subserosa and 
serosa.69,70 Smooth muscle cells contribute more to absolute collagen 
formation than fibroblasts. 
Mucosal resurfacing is rapid in the GI tract and mucosal continuity is 
fully reestablished within 1-2 weeks, over a base of granulomatous 
tissue consisting of proliferating smooth muscle cells and fibroblasts.70 
However, if the injury is severe or is accompanied by tissue destruction 
or bacterial spillage, the process may take longer. Angiogenesis starts 
as early as 2–3 days after injury,71  accompanied by reconstitution of 
the submucosal collagenous network which is important for epithelial 
regeneration. This is followed by remodeling and thinning of the 
anastomosis. The muscularis mucosae and muscularis propria stay 
disorganized, however, allowing the repair process to be recognized 
even 1 yr after operation.69 
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3.6.3 Anastomotic Strength. 
The continuity of the colon is reestablished by deposition of new 
collagen based matrix that bridges the anastomosis. Collagen types I, 
III, and V are the major isotypes during colon repair, type I being the 
predominant one. In general, collagen accumulation and deposition 
represent the balance between new synthesis and degradation. 
3.6.4 Bursting Pressure. 
Immediately after its creation, and for 2–3 days thereafter, the 
anastomosis is held together by surgically placed sutures and sealed 
by a fibrin clot. During this time period, there is little or no new matrix 
synthesis, but there is marked and sustained lysis of the structural 
collagen matrix. After 3 days there is a noticeable increase in strength 
of the anastomosis.68 After day 7, experimental anastomoses acquire 
their full mechanical strength and rupture outside the suture site (Fig. 
2) (5). This is owing to the rigidity of the newly established connection 
compared with the adjacent bowel and to an increase in bursting 
strength of the colon remote from the anastomosis.69 
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3.6.5 Collagen Synthesis and Collagenase Breakdown. 
Fibronectin, a high molecular weight glycoprotein, usually is expressed 
at low concentrations in the healthy submucosa. Several hours after 
injury, its expression is induced in the submucosa, serosa, and muscle 
layers; the expression is strongest around days 3–5. Fibronectin serves 
as a scaffold for infiltrating cells and as provisional matrix. The 
expression declines during the proliferative phase.70 Basal expression 
of collagen I and II is found in the lamina propria and submucosa of the 
uninjured colon. After injury, collagen gene expression, as measured 
by Northern blotting, is strongly activated with a peak around day 3 for 
collagen I and around day 2 for collagen III.71 Immunohistochemical 
staining, however, shows a strong decline in staining for both collagens 
at days 2 and 3 with a gradual increase until day 7.74 This loss of 
collagen is most marked in the proximal and distal 2.5 cm from the 
anastomosis73 and signifies increased breakdown of collagen by 
collagenases like MMPs. In the basal lamina, type V collagen as well 
as laminin shows a similar pattern of staining. Small-bowel 
anastomoses have a faster and more pronounced collagen synthesis 
compared with colon anastomoses.72 Furthermore, collagen 
breakdown is almost negligible in small-bowel anastomoses compared 
with the colon.71,73,76 This may account for the lower failure rate of 
small-bowel anastomoses.73 
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The synthesis and deposition of collagen as well as degradation of 
preformed collagen occur simultaneously in the healing process 
anddetermine wound strength and the balance between these two 
factors determines the strength and integrity of the wound in the early 
period following injury.74 The initial breakdown of collagens at the 
anastomosis is partially due to an increased collagenase activity.72  
Specific collagenases break up the triple helix and render it more 
susceptible to breakdown by other enzymes. The activity of the 
collagenases is regulated by their counterparts, the tissue inhibitors of 
metalloproteinases. Collagenases are induced within a few hours after 
injury and are strictly located at the anastomosis,114 followed shortly by 
tissue inhibitors of metalloproteinases which regulate collagenase 
activity.75 The main sources of collagenases are the granulocytes and 
fibroblasts and also the intraluminal. Overproduction of collagenases 
during infections or abscess formation can lead to higher dehiscence 
rate.76  
The data on collagenase inhibitors and colon healing are controversial 
as both positive and negative effects have been shown. It has to be 
kept in mind, however, that synthetic inhibitors of metalloproteinases 
have other collateral and distinct functions such as inhibition of tumour 
necrosis factor-α formation77 and inhibition of angiogenesis.78 A recent 
human study demonstrated that resected colon tissue specimens from 
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patients who subsequently developed an anastomotic leak had 
decreased collagen I and III concentrations and decreased overall 
collagen content compared with normal healing controls.79 There was 
also an increased detection rate of matrix metalloproteinase-13 in the 
anastomotic failure group. Since the differences in collagen expression 
were already present at the time of the operation, it suggests that there 
may be genotypic or phenotypic alterations in bowel wall collagen 
composition that could explain why even under the best conditions 
some anastomoses fail to heal with no obvious clinical risk factor being 
present.  
3.6.6 Growth Factor Expression. 
The expression of growth factors with regard to healing of colonic 
anastomoses has not yet been well investigated. Some data are 
available on mucosal repair during colitis80 and anastomotic healing.81 
A few of the growth factors possibly involved in colonic healing are 
mentioned below. 
Epidermal growth factor is a potent stimulator of cell proliferation in the 
GI tract. It promotes intestinal repair and modulates polyamine 
synthesis. The receptor for epidermal growth factor is widely expressed 
in the intact GI tract, and increased expression is detected in colonic 
epithelium and fibroblasts around day 7 after surgery. However, the 
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complementary DNA for epidermal growth factor is not up-regulated at 
the anastomosis.70 More research is required to identify if epidermal 
growth factor plays a role in anastomotic healing. 
Transforming growth factor (TGF)-β is mainly produced in the epithelial 
layer in the intestine. It inhibits the proliferation of fibroblasts and 
epithelial cells, modulates lymphocyte function, and induces and 
stimulates fibroblast matrix synthesis. TGF-β knockout mice have 
diffuse intestinal inflammation. TGF-β expression in healing colon 
anastomoses correlates with increased collagen I expression85 and 
Single TGF-β application accelerates gastric incisional healing in a 
rabbit model82 underscoring the significance of TGF-β in bowel healing. 
Insulin-like growth factor (IGF) enhances epithelial repair and 
stimulates cell proliferation. Intraperitoneal or systemic administration 
of IGF-I increases bursting pressure of anastomoses,83 but this effect 
may possibly be due to enhanced collagen deposition.84 However, 
growth hormone, which mediates IGF release, improves colon healing 
by increasing collagen deposition in a dose-dependent manner.85 
Keratinocyte growth factor (KGF) is synthesized by stromal fibroblasts 
but acts in a paracrine manner on epithelial proliferation. KGF receptor 
and messenger RNA are expressed throughout the entire intestine. 
During colon anastomotic healing, KGF increases bursting pressure 
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during the first postoperative week. KGF reduces local inflammation 
and increases epithelial proliferation but does not increase collagen 
synthesis at the anastomosis.86 A combination of KGF and IGF has 
synergistic effects on the healing of experimental colon anastomoses.87 
 
3.7 Butyrate and its Role in Colonic Healing 
Butyrate is a four carbon molecule formed from bacterial fermentation 
of complex carbohydrates in the colon. It has a variety of effects with 
reference to colonocyte nutrition, colonic epithelial physiology and 
disease.  
Butyrate is the most important Short Chain Fatty Acid (SCFA) and is 
preferentially metabolized by colonic mucosa when compared to 
propionate and acetate. The dependence of the colon related to the 
oxidation of SCFA increases towards the rectum, and 70% of the 
oxygen consumed by the colonic epithelial cells is used in the oxidation 
of SCFA.87 
The intraluminal environment of the colon differs from the rest of the 
intestinal tract due to the presence of a variety of bacteria that colonise 
the colon. These organisms are mainly anaerobic and digest the 
undigested food products in the effluent delivered to the colon, 
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especially the complex sugars contained in dietary fibre. This 
fermentation of sugars is an important source of colonic gases such as 
hydrogen, methane and carbon dioxide. Digestion of bile salts in 
malabsorbed long-chain fatty acids leads to the formation of potent 
secretagogues which causes diarrhoea. 
The fermentation of complex sugars by the colonic bacteria leads to 
the formation of short-chain fatty acids (SCFAs), namely, butyrate, 
propionate and acetate. These SCFAs, especially butyrate are 
important sources of colonic nutrition with butyrate providing upto 80% 
of colonocyte energy. They are actively and passively transported into 
the cell where they provide energy through the β-oxidation pathway. 
Fermentation of dietary fibre by colonic bacteria can provide upto 500 
calories/day of the overall nutritional needs.88 
The physiological role of butyrate and the other SCFAs in the colon has 
been the reason that much interest has been generated over their 
possible role in colonic healing. Recently, there have been many 
studies looking at the role of butyrate in the pathophysiology and 
treatment of colonic disease and injury. There have been encouraging 
results and the role of butyrate in colonic healing has now been firmly 
established.  
 38 
It has been found that a covering stoma weakened colonic 
anastomoses in rats leading to higher leak rates as identified by 
radiological studies.89 This could be attributed to the absence of short 
chain fatty acids (SCFAs) in the colon due to diversion, though more 
confirmatory research is required. It has also been found that butyrate 
enemas strengthened the anastomoses in rats exposed to 
radiotherapy.90 
Earlier researchers have proved that a continuous infusion of a mixture 
of SCFAs significantly strengthened a left colonic anastomosis in rats.91 
This study by Rolandelli et al used a mixture of acetate, propionate and 
butyrate as a continuous infusion through the proximal colon to bathe a 
distal colonic anastomosis. They found a significant difference in the 
bursting pressures as well as the bursting wall tension of the 
anastomoses when compared to controls that were given a solution of 
electrolytes. 
Continuous infusion of solution is not a feasible clinical option and it 
was necessary to identify usable routes to provide SCFA to the healing 
anastomosis. A further study by Rolandelli et al found that intravenous 
infusion of butyrate also improved the mechanical strength of colonic 
anastomosis with significant increase in bursting pressure and bursting 
wall tension over a group not given butyrate.92 
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There has been much research into the role of butyrate in the 
pathogenesis and treatment of ulcerative colitis (UC). Damage to 
colonic epithelial cells with impaired cell metabolism and barrier 
function is a hallmark of active UC.93 In drug induced UC, butyrate has 
been found to have a definite cytoprotective effect.94,95 Butyrate has 
been used experimentally with favourable results in the treatment of 
ulcerative colitis.96,97,98,99 The therapeutic efficacy of butyrate could be 
explained on the basis of the fact that butyrate serves as the major 
source of energy for colonocytes, increases mucosal proliferation, 
promotes cell differentiation, and improves barrier function.91 It has 
been assumed that the protective effect of butyrate in these diseases 
results predominantly from influencing energy availability in the 
colonocyte, because it is the primary source of energy in these cells .100  
However, the cellular signaling events initiated by butyrate to carry out 
its protective effect have not been completely elucidated. 
Diversion colitis is a condition that frequently develops in segments of 
the colorectum after surgical diversion of the fecal stream. It persists 
indefinitely unless the excluded segment is reanastomosed and 
probably represents an inflammatory state resulting from a nutritional 
deficiency in the lumen of the colonic epithelium. Harig et al have 
demonstrated amelioration of symptoms and healing of the colonic 
epithelium with instillation of a solution of SCFAs over a period of four 
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to six weeks.101 Radiation proctocolitis is a complication of radiation 
therapy to the pelvis for malignant disease. The acute haemorrhagic 
form is the most severe and can be fatal. This disease has been 
resistant to the many forms of therapy tried. There is now, however, 
evidence showing the effectiveness of intraluminal butyrate infusion in 
the treatment of this condition.102 This is another piece of experimental 
evidence to suggest the role of butyrate in colonic healing. 
It has been postulated that impaired healing in the colon may result 
from an increased breakdown of collagen by increased activity of 
collagenases.103 These collagenases are produced in the colon by the 
intraluminal bacteria and the endotoxins secreted by these bacteria 
activate collagenases. As butyrate is the preferred form of nutrition for 
the colonocyte,104 it has been the subject of much recent study for a 
possible role in facilitating early colonic healing.
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4.0 Materials and Methods 
4.1 Animal Experiments 
Forty male albino rats of the Wistar strain weighing between 200 – 250 
grams were used for the experiment. The animals were fed a fibre-free 
diet to minimise the production of SCFAs from the fibre in the colon. 
This was begun 2 days before the initial operation and continued till the 
end of the experiment. The diet used was a specially prepared purified 
fibre free diet based on the American Institute of Nutrition (AIN)-93M 
diet.105 The diet was prepared initially in a powder form and 
reconstituted every day with water to make a semi-solid diet. 
After 48 hours, the rats were anaesthetised using ether chamber and 
intra-peritoneal ketamine (50mg/kg) and a midline laparotomy was 
done. The colon was first washed out with normal saline and then 
transected in two places preserving the marginal vessels (Fig 6.1). The 
ascending colon was transected about 3 cms from the ileo-caecal 
junction and the descending colon about 3 cms from the peritoneal 
reflection. Specimens were taken from both areas, frozen immediately 
in liquid nitrogen and stored at -70˚C. An end-to-end anastomosis was 
carried out with a single layer of interrupted 6. 0 proline sutures (Fig 
6.2, 6.3). A diversion caecostomy was carried out and the abdomen 
closed in layers.  
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The animals were then injected 20 ml of saline subcutaneously to 
prevent post-operative dehydration. The rats were continued on the 
fibre-free diet for the remainder of the experiment.  
The rats were randomly assigned to two groups – butyrate and control. 
The rats in the butyrate group were given 10 ml of 140 mmol solution 
containing 80 mmol of butyrate and 60 mmol of sodium chloride as an 
enema daily beginning from the third post-operative day. The rats in 
the control group were given 10 ml of 140 mmol sodium chloride 
enemas. The enemas were instilled in the rectum using a non-
traumatic plastic cannula.  
The rats were anaesthetised again on the seventh post operative day 
and the bursting pressure was measured in vivo without disturbing the 
adhesions around the anastomosis using an electronic transducer 
(Hewlett Packard, 78353B) (Fig 6.4, 6.5). The colon was infused with 
saline at a constant rate and the pressure curve was observed on the 
monitor. At the point when the colon burst, there was a sudden drop in 
pressure as evidenced by the pressure curve and this pressure was 
taken as the bursting pressure. It was noted in each case whether the 
colon burst at the anastomosis or away from it.  
The anastomotic site was then transected longitudinally including 1 cm 
from the anastomosis on each side. The anastomotic circumference 
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was then measured. Samples were taken from the anastomotic sites 
as well as a virgin area of colon and frozen and stored as before. The 
rats were then sacrificed by transecting the inferior venacava. The rats 
were stored in cages housing 4 animals pre-operatively and in 
individual cages post-operatively. The methods used were examined 
by the institutional animal ethics committee and the use of the animals 
was sanctioned. 
 
4.2 Calculation of Bursting Wall Tension 
There are two described methods of testing experimental 
anastomoses. The first is the identification of breakdown or leakage by 
radiological methods that has been recently adapted to animal 
models.106 The second method is the testing of the mechanical 
strength of the anastomosis. This can be done in two ways – by 
applying a longitudinal stretch force or by increasing intraluminal 
pressure. It has been found that increasing the intraluminal pressure 
provides a better reflection of the physiological strain that longitudinal 
stretching.107,108 It has also been shown that the bowel wall tension 
best characterises the forces responsible for loss of anastomotic 
continuity.109 
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The strength of the anastomosis in this study was measured by the 
Bursting Wall Tension (BWT) in dyne10-3/cm based on Laplace’s law. It 
was calculated using the Bursting Pressure (BP) and the anastomotic 
circumference. 
BWT = BP x 1.36 x anastomotic circumference 
    2π 
 
4.3 Statistical Analysis 
The results were tabulated on a spreadsheet and statistical analysis 
was done using SPSS software. 
 
4.4 Estimation of Matrix Metalloproteinases (MMPs) 
The estimation of MMPs was carried out by zymography as described 
by Rosario et al.110 There were 5 specimens for each animal in the 
study – two specimens from the distal and proximal colon taken at the 
first laparotomy and 3 specimens taken at the second laparotomy from 
the distal and proximal anastomosis and from a virgin area of colon 
between the two anastomoses. The specimens were frozen using 
liquid nitrogen and stored at -70˚C at operation. 
 45 
4.4.1 Homogenisation 
At the time of MMP estimation, they were washed with cold phosphate-
buffered saline (PBS) to remove any blood clots of attached fat. They 
were then hand-homogenised on ice with PBS and a serine and 
cysteine protease inhibitor cocktail (4,2 Amino-ethyl benzene sulphonyl 
hydrochloride with leupeptin, aprotinin and E64). This cocktail inhibits 
the serine and cysteine proteases which cleave the MMPs. They are 
inactive when the samples are stored at -70˚C and begin to act once 
the temperature rises after removal from storage. The fat and other 
proteins were removed and the homogenate was centrifuged for half 
an hour at 14000 G (13,400 RPM) (Fig. 6.6). 
4.4.2 Protein estimation 
The amount of protein present in the homogenate was then estimated 
using Lowry’s protein assay and bovine serum albumin as a standard. 
The amount of protein in the homogenate would differ based on the 
initial weight of the specimen. Hence, a protein assay was necessary 
before running the gels in order to provide a constant weight of protein 
from all the specimens. Lowrys reagent (Copper Sulphate, Sodium 
potassium tartrate, Sodium bicarbonate and Sodium hydroxide) was 
added to 5 µl of the specimen and incubated for 10 minutes. Folin’s 
(phosphor-18-tungstic acid) phenol reagent was then added and 
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incubated for half an hour. The protein content was then estimated by 
spectrophotometry. 
4.4.3 Preparation of the Gel 
The gel used for zymography is based on the polymerisation of 
acrilamide and bis-acrilamide. The polymerisation converts the liquid 
constituents into the gel. Following standardisation, a 1% gelatine 
based gel was used. 10 µg of gelatine was dissolved in 5 ml of water 
and added to 2.5 ml each of pre-prepared solutions A and C. Solution 
A contained stable acrilamide and bis-acrilamide and Solution C 
contained stable Temed, Sodium dodecyl suphate (SDS) and TrisH. 
Then 10 mg of Ammonium persulphate was added to the solution and 
the liquid loaded into a Biorad electrophoresis assembly between 
plates. A solvent is used to remove any bubbles that may have formed. 
The gel is formed by the polymerisation of acrilamide and bis-
acrilamide. The Temed is first made unstable by the ammonium 
persulphate. This ionises the acrilamide and bis-acrilamide and they 
polymerise when in the ionised state. The process takes around 10 
minutes following which the gel sets.  
The loading gel was then added. This has a smaller concentration of 
acrilamide and bis-acrilamide with glycinate and chloride. The purpose 
is to suspend the sample proteins between the glycinate and chloride 
 47 
so that they move down the gel in a constriction band. A template was 
used to make the wells and after setting, the assembly was stored at 
4˚C till use. 
4.4.4 Loading the Specimens 
The specimen proteins were than added to a running buffer to make up 
10µl and 5µl of loading buffer were added to make 15µl. The loading 
buffer contained Bromophenol blue, SDS, TRIS and glycerol. The 
running buffer contained SDS, TRIS and glycine. The mixture of 
sample, loading buffer and running buffer were then loaded in the wells 
along with a commercially available protein mix containing proteins of 
different molecular weights as a control (Fig. 6.7, 6.8). The samples 
were loaded at 4˚C and were then electrophoresed at 120V for one and 
a half hours at 4˚C (Fig 6.9). 
4.4.5 Incubation 
After electrophoresis, the gels were washed and Triton X, a 
commercially prepared detergent was added and incubated for one 
and a half hours. Triton X has two functions. It excludes the SDS from 
the gel and denatures it and also renatures MMPs. SDS in the gel 
denature MMPs causing them to fold. This deactivates them preventing 
any action of the MMPs on the gel during electrophoresis. Running the 
electrophoresis at 4˚C also prevents action of the MMPs as the ideal 
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temperature for the action of MMPs is 37˚C. Once the electrophoresis 
is complete, the proteins would have moved to their respective zones 
based on the molecular weight. Triton X then removes the SDS which 
allows renaturation of the MMPs. The gels were then incubated for 18 
hours at 37˚C and a pH of 7.5 with an incubation buffer containing 
TRIS, Calcium chloride and BRIG (a commercial detergent). Calcium 
chloride also acts as an activator of MMPs. After incubation, the gels 
are stained with a stain containing methanol, acetic acid, Coomassie 
brilliant blue and water (Fig. 6.10). They were then de-stained and the 
gels were read. The MMPs digest the gelatine in the gel during the 
incubation period and this is seen as a band of clearing in the blue 
stained gel. 
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5.0 Results 
5.1 Experimental results 
Of the 40 rats used, 9 died during the course of the  
5.0 Results 
5.1 Experimental results 
Of the 40 rats used, 9 died during the course of the experiment. Six 
rats died during anaesthesia or in the immediate post-operative period. 
Of these, 4 animals died in the ether chamber possibly due to a 
reaction to ether or a vasovagal attack. One animal did not wake up 
after the operation and another animal died of acute cardiac 
tamponade as the post operative dose of saline was injected into the 
thorax instead of subcutaneously. Three animals died during the post 
operative period. One died on the first post-operative day possibly due 
to aspiration and two died on the fifth post-operative day due to 
intestinal obstruction. There were no demonstrable anastomotic leaks 
during the study. 
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5.2 Animals Excluded from the Study 
Of the 31 animals that survived till the seventh post-operative day, 8 
animals could not be used for the study. Of these, 2 animals missed 
the enemas on certain days and 2 animals were not fed the fibre-free 
diet on certain days. While standardising the procedure for testing the 
bursting pressure, there were gross errors in 4 animals leading to their 
exclusion from the study. 
 
5.3 Strength of the anastomoses 
The mean Bursting Pressure (BP) for the animals given saline was 
150.5 mm of Hg for the ascending colon and 168.54 mm of Hg for the 
descending colon. The mean BP for the animals given butyrate was 
168.54 mm of Hg for the ascending colon and 188.62 mm of Hg for the 
descending colon (Chart 7.1). The difference in the means between the 
butyrate and saline arms was not statistically significant with p values 
of 0.3 for the ascending colon and 0.06 for the descending colon. 
The mean anastomotic circumference was 1.37 cm for the ascending 
colon and 1.47 cm for the descending colon in the rats given saline and 
1.64 cm and 1.68 cm for the ascending and descending colon 
respectively for the rats given butyrate (Chart 7.2). The difference in 
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the means between the butyrate and saline arms was not statistically 
significant with p values of 0.03 and 0.27 for the ascending and 
descending colon respectively. 
The bursting wall tension (BWT) for each anastomosis was calculated 
from the bursting pressure and the anastomotic circumference using 
the formula given above based on Laplace’s Law. It was found that the 
mean BWT of the proximal colonic anastomosis was 48.9 dyne10-3/cm 
for rats given saline and 64.71 dyne10-3/cm for rats given butyrate 
(Chart 7.3). The distal colonic anastomotic BWT was 51.44 dyne10-
3/cm for rats given saline and 72.38 dyne10-3/cm for rats given butyrate 
(Chart 7.4). There was a significant difference in the BWTs of animals 
in the butyrate and control group as calculated by the Student’s t-test 
with p values of 0.04 for the ascending colon and 0.01 for the 
descending colon. 
It was also noted that the colon burst away from the anastomosis in 36 
out of 46 anastomoses, 
 
5.4 Matrix Metalloproteinase Zymography 
The zymogram of the MMPs showed increased activity of MMP 2 in all 
the post operative samples as evidenced by increased clearance of the 
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blue-stained gelatine (Fig 6.11, 6.12).  The increased activity was more 
pronounced in the animals given butyrate at the sites of the 
anastomoses. There was a smaller increase in the animals given saline 
as well as at the virgin area of colon. However, there was an increased 
activity of MMP 9 in the post operative specimens of animals given 
saline when compared to butyrate. 
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6.0 Figures 
 
Figure 6.1. 
  
 
 
Figure 6.1.  The proximal colon before transaction. 
 
 
Figure 6.2. 
 
 
            
Figure 6.2.  Single layered anastomosis sutured with 
 
                                          interrupted 6/0 proline sutures. 
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Figure 6.3. 
 
 
 
Figure  6.3. The completed anastomoses. 
 
 
 
Figure 6.4. 
  
                      
 
 
                        Figure  6.4.  Bursting pressure measurement 
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Figure 6.5. 
 
 
 
Figure 6.5.  Bursting pressure measurement.  Infusion catheter  
                    and pressure catheter are seen on either sides  
                    of the anastomosis. Small bowel and omental                    
                    adhesions are noted around the bowel. 
 
Figure 6.6. 
 
 
                      
                     Figure 6.6. Centrifuging 
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Figure 6.7. 
 
 
 
 
                      Figure 6.7.  Loading the gels 
 
Figure 6.8. 
 
 
 
                      
Figure 6.8.  Loading the gels. 
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Figure 6.9. 
 
  
 
Figure 6.9. Electrophoresis 
 
 
 
Figure 6.10. 
 
 
 
 
Figure 6.10. Staining 
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Figure 6.11. 
 
 
 
 
Figure 11.  Zymogram after saline.  
                   Expression of MMP-2 and MMP-9 is seen. 
 
 
Figure 6.12. 
 
 
 
 
Figure 12.  Zymogram after butyrate. Decreased expression 
of MMP-2  and absence of expression of MMP-9. 
 Legend 
P0 - Day 0. Proximal colon 
D0 - Day 0. Distal colon 
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7.0 Charts 
7.1. Bursting pressures with Saline and Butyrate  
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7.2 Anastomotic Circumferences with Saline & Butyrate 
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7.3. Ascending Colon Bursting Wall Tension 
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8.0 Discussion 
Colonic anastomoses have proved a challenge to surgeons for many 
decades due to the high rates of complications associated with them. 
Much work has gone into identifying the myriad factors associated with 
anastomotic healing and dehiscence in the colon. However, there still 
remains much room for experimentation before an ideal procedure can 
be identified and the rates of morbidity decreased. 
This study was carried out to look at colonic anastomotic healing from 
a physiological perspective. With butyrate being a primary energy 
source of the colon, it was assumed that providing butyrate to a colon 
that was starved of it due to diversion would hasten healing. 
Preliminary work by other investigators in this field seemed to bear out 
this fact. This study has proved that providing intraluminal butyrate to a 
healing colon in the rat significantly strengthens the anastomosis and 
increases both the bursting pressure and the bowel wall tension. 
 The rat model was selected for this study as there was already some 
work in rats showing enhanced healing with butyrate.91-95 The 
experimental model used was developed with some initial hiccoughs, 
especially with anaesthesia. Most other studies have used a single 
colonic anastomosis to study wound healing, usually in the right 
colon.93-95 However, in this study, 2 anastomoses were used – in the 
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right and the left colon and it was found that this was a safe process, 
well tolerated by the animals.  
The delivery of the butyrate was an area of struggle – with the rat as 
well as the method. There was no way of ensuring that the butyrate 
remained in the colon for sufficient time although considering the 
results, there was enough time for adequate action of the butyrate on 
the anastomoses. The other difficulty was that a few animals 
developed mucus or fecal plugs that prevented the butyrate from 
completely bathing the colon. In these animals, there was a 
corresponding drop in the bursting pressures and bowel wall tension. 
The study shows that intraluminal butyrate strengthens colonic 
anastomoses both in the ascending and descending colon. Till date, 
most studies have dealt with the descending colon.92-95 It was 
hypothesised that butyrate had a stronger action in the left colon. 
However, this study proves that there is a significant increase in the 
strength of even the ascending colonic anastomosis though the right 
colon anastomosis remains weaker than the left colon anastomosis in 
terms of bursting pressure and bowel wall tension. The bursting 
pressures and bowel wall tension of the right and left colon werehigher 
than those in some of the previouls studies as the rats used in those 
studies were of a different strain, namely Sprague-Dawley.  
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It was found that in a number of rats, the colon burst at a site away 
from the anastomosis. In all these rats, the site of bursting was within 1 
cm from the anastomosis. This finding is in keeping with previous 
studies111 and the possible explanation is that the zone of healing 
extends on either side of the anastomosis and in some instances, the 
colon is weakest at this point. This is because, the mechanical strength 
provided by the suture material, especially a non-absorbable one as in 
this case adds to the strength at the suture line when compared to a 
point just away from it. 
An observation was made that there appeared to be more adhesions of 
the small bowel, omentum and seminal vesicles to the site of the 
anastomosis in the animals given saline enemas. As this was not part 
of the study protocol, there were no objective measurements of the 
adhesions that formed by the seventh post-operative day. However, 
towards the end of the study it appeared that animals given saline did 
have more adhesions than those given butyrate. While this may be an 
anecdotal finding, there is possibly a scientific explanation. It has been 
suggested that butyrate cytoprotection of colonic epithelial cells may be 
mediated through inhibition of heat Shock Protein 70 (45).112 The heat 
shock proteins or stress proteins are important in the cellular response 
to stress and in cellular homeostatic functions such as protein 
synthesis and protein transport across membranes. Emerging evidence 
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supports a role for HSP in the inflammatory response, suggesting 
participation in cytokine signal transduction and the control of cytokine 
gene expression. Butyrate increased colonic epithelial cell survival in 
the face of lethal heat stress and significantly reduced HSP 70 
expression in this study by Venkatraman et al. This indicates that 
butyrate plays a role in healing by reducing the inflammatory reponse. 
The reduction of inflammation would explain the decreased adhesions 
in the rats given butyrate when compared to the rats given saline. 
The expression of Matrix Metalloproteinases (MMPs) was increased 
following anastomosis. There was an increase in both rats treated with 
butyrate and treated with saline. There was no increase in MMP2, but 
in MMP 9 there was a obvious increase in expression in the rats 
treated with saline following operation. This was an observational 
finding based on the clearance of the gelatine. Quantitative analysis of 
the proteins could not be carried out. 
This finding needs to be studied further. It was planned to run reverse 
zymography gels to ascertain the expression of tissue inhibitors of 
metalloproteinase (TIMPs). However, due to technical difficulties in 
procuring the pure MMPs required to run the gel, this part of the study 
was unsuccessful. The small amounts of MMPs available commercially 
at high prices were not sufficient to impregnate an entire gel in 
sufficient quantity to view activity of TIMPs. If there was an increased 
 59 
activity of TIMPs as well, this would suggest a rapid rate of collagen 
based remodelling which would explain the strengthening of the 
anastomoses by butyrate. Further study of TIMPs is planned once 
MMPs can be easily synthesised in the lab. This is being planned using 
human fibroblast cell line which expresses high amounts of MMPs. 
The expression of MMP 9 was increased in the rats treated with saline. 
This finding would suggest a role of butyrate in decreasing the collagen 
breakdown by MMP 9, leading to enhanced healing. However, in the 
light of the increased expression of MMP 2 in the butyrate treated rats, 
this finding needs to be viewed with caution and further studies are 
required. 
Chowcat et al investigated the expression of collagenases and tissue 
inhibitor of metalloproteinases (TIMPs) using antibodies to these 
proteins at the site of colonic anastomoses.117 They found that the 
expression of MMPs and TIMPs was limited to the suture line. 
However, in this study, it was found that there was increased 
expression of MMPs even at a site away from the anastomosis when 
compared to the pre-operative expression. This would suggest that that 
trauma to the colon leads to increased synthesis of MMPs throughout 
the colonic mucosa with increased concentration at the site of the 
anastomosis.
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8.0 Conclusions 
i. Local instillation of butyrate significantly strengthens colonic 
anastomoses as measured by the bursting wall tension. 
ii. The effect of butyrate increases both the bursting pressure and 
the circumference of the anastomosis. 
iii. There is a difference in the strength of proximal and distal colonic 
anastomoses. 
iv. There was an increase in the expression of Matrix 
metalloproteinases in all the post operative specimens. There 
was no difference in the expression of MMP2, but an increase in 
the expression of MMP9 between the butyrate and saline arms. 
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9.0 Clinical Significance and Need of Further 
Research 
i. The fact that butyrate strengthens colonic anastomoses leads to 
many possibilities in clinical practice. The main concern needs 
to be an ideal drug delivery system that would deliver the 
butyrate intraluminally to the colon in the post-operative period. 
ii.  The finding that MMP-9 shows diminished secretion followed by 
treatment with butyrate suggests that there may be a role for 
MMP inhibitors to be used in the post-operative period to 
strengthen colonic anastomoses. However, this needs much 
further work before it can be conclusively justified. 
iii. The role of inflammatory mediators like HSP and cytokines 
needs to be evaluated with regard to butyrate, especially as 
there appeared to be reduced inflammatory changes in the 
animals treated with butyrate. 
iv. The ideal study would be a time-based study where animals 
were sacrificed and tested at different times in the healing 
process, say at days 2,4,6,8 and 10 and then at 2 weeks and 4 
weeks after the initial operation. This would give us some idea 
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about the exact step and the time in wound healing sequence of 
events that is affected by butyrate. 
v. There would need to be a multi-factorial approach to the 
experimental testing of the effect of butyrate on wound healing. 
This would allow the factors involved to be detected early and 
treatment mechanisms to be tested based on the factors 
implicated. 
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  Appendix 1     
The Effect of Butyrate in the Healing of Colonic Anastomoses in Rats. 
  Spread Sheet     
Rat 
Number 
Enema Proximal 
Colon 
Bursting 
Pressure 
Distal 
colon 
Bursting 
Pressure 
Proximal 
Colon 
Circum-
ference 
Distal 
colon 
Circum-
ference 
Proximal 
Colon 
Bursting 
Wall 
Tension 
Distal 
colon 
Bursting 
Wall 
Tension 
3 S 84 175  -  -  -  - 
4 B 106 194  -  -  -  - 
6 B 110 188  -  -  -  - 
7 S 88 168  -  -  -  - 
10 S 118 122 1.6 1.7 40.88 44.91 
11 B 196 208 2 2.2 84.89 99.09 
12 S 160 100 1.2 1.5 41.57 32.48 
16 S 116 174 1.2 2.3 30.14 86.66 
17 B 122 148 1.2 2 31.7 64.1 
22 B 204 212 2 1.8 83.94 85.76 
23 S 206 110 1.5 1.8 71.43 42.87 
24 B 156 188 1.2 1.3 57.43 89.56 
25 B 188 208 2 2.2 85.5 99.09 
27 B 196 172 1.9 2.5 80.65 93.12 
28 S 147 191 1.3 1.3 44.56 53.77 
29 S 137 141 1.5 1.7 44.5 51.91 
30 S 148 162 1.2 1.5 41.67 52.62 
31 B 176 180 1.7 1.8 64.79 70.16 
32 S 151 202 1.5 1.2 49.05 52.49 
33 B 141 170 2 0.9 45.8 33.13 
34 S 250 191 1.3 1.2 70.38 49.64 
35 B 165 170 1.3 1.6 46.45 58.9 
36 S 105 177 0.9 0.8 20.46 30.66 
37 B 191 210 1.4 1.3 57.9 59.12 
38 S 230 171 1.3 1.1 59.77 40.73 
39 B 240 204 1.4 0.9 72.76 44.17 
40 S 167 242 1.9 1.5 72.33 78.61 
  
S = Saline   
         
  
B = Butyrate 
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Appendix 2. 
Three Dimensional Structure of Metalloproteinases 
 
 
Appendix 2.  Ribbon Diagram of MMP Structures. 
Three dimensional (3D) structure of matrixins showing the ribbon diagram of MMP 
structures. A, ProMMP-2–TIMP-2 complex (1GXD) is shown. Orange indicates 
propeptide; green, catalytic domain; pink, fibronectin domains; red, hemopexin 
domain; and blue, TIMP-2. Zinc atoms are pink, and calcium atoms are gray. B, In the 
MMP-2 propeptide, the cysteine of the cysteine switch motif is shown. The arrow 
indicates the position of the initial cleavage resulting in partial activation. C, The 
catalytic domain of MMP-1 is shown. 
The ß-strands are numbered I through V; the -helices are labeled A through C. The 
N-terminal (N) to C-terminal (C) order of the ß-stands and -helices is I-A-II-III-IV-V-
B-C. The histidines coordinating the active-site zinc and the active-site glutamic acid 
are shown. D, The 3 fibronectin domains of MMP-240 are shown with their 2 disulfide 
bonds each. E, The hemopexin domain of MMP-1128 with 4 ß-propeller blades is 
shown. A disulfide bond is seen between blades I and IV.  
This figure was prepared with a Swiss PDB Viewer and rendered with POV-Ray.  
Visse R, Nagase H. Matrix Metalloproteinases and Tissue Inhibitors of Metallo-proteinases. 
Structure, Function, and Biochemistry Circulation Research. 2003; 92:827-39. 
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Appendix 3.  
Domain Arrangements of Vertebrate Matrixins 
 
Appendix 3.  Domain Arrangements of Vertebrate Matrixins 
The propeptide domain (about 80 amino acids) has a conserved unique sequence.  
The catalytic domain (about 170 amino acids) contains a zinc binding motif 
HEXXHXXGXXH and a conserved methionine, which forms a unique "Met-turn" 
structure. This domain consists of a five-stranded -sheet, three -helices, and 
bridging loops. The catalytic domains of matrixins have an additional structural zinc 
ion and 2-3 calcium ions, which are required for the stability and the expression of 
enzymic activity. MMP-2 and MMP-9 have three repeats of fibronectin-type II domain 
inserted in the catalytic domain.  
The C-terminal hemopexin-like domain (about 210 amino acids) has an ellipsoidal 
disk shape with a four bladed -propeller structure; each blade consists of four 
antiparallel -strands and an -helix.  
Nagase H, Woessner JF Jr. Matrix Metalloproteinases. J Biol Chem. 1999; Jul 30; 
274(31):21491-4. 
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